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Abstract In order to engineer a new type of catalytic antibody, 
we attempt to use a monoclonal antibody L chain as a host protein 
for a porphyrin. TCPP (meso-tetrakis(4_carboxypbenyl)por- 
phyine) was chemically synthesized and Balblc mice were immu- 
nized using TCPP as a hapten. Two bybridoma cells (03-1,13-l), 
that produce monoclonal antibody against TCPP, were obtained. 
Genes for both H and L chains of monoclonal antibodies were 
cloned, sequenced and overexpressed using E. coli as a host. 
ELISA and fluorescence quenching method show that the inde- 
pendent antibody L chains from both Mab03-1 and MablI1 have 
specific interaction with TCPP. Furthermore, the recombinant 
antibody L chain from Mabl3-1 exhibits much higher peroxidase 
activity than TCPP Fe(II1) alone. The enzyme activity was 
detectable with pyrogallol and ABTS (2,2-azinobis-3-etb- 
> lbenzthiazolin&sulfonic acid) but not with catechol. This new 
catalytic antibody was extremely thermostable. Optimum tem- 
perature of the peroxidase reaction by the complex of 13-1L chain 
and TCPP Fe(II1) was 9O”C, while that the TCPP Fe(II1) alone 
YI as 60°C. 
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1. Introduction 
Antibodies have been demonstrated to catalyze a wide vari- 
t ty of transformations such as ester hydrolysis [l-3], pericyclic 
41, photochemical [5], ligand substitution [6] and redox reac- 
Ions [7]. These new antibodies were designated as catalytic 
ntibodies or abzymes. We attempt here to engineer a new way 
3 generate catalytic antibody with peroxidase activity. We 
hose a porphyrin as a hapten based on the fact that active 
enters of various peroxidases, catalases and cytochromes con- 
’ ist of the porphyrin molecule encapsulated by a protein mole- 
c ule. In these cases, the protein has the role of a host molecule 
13 enhance the function of porphyrin. Therefore, we planned 
10 use monoclonal antibodies as a kind of host protein to 
I nhance function of porphyrin molecule. It was previously re- 
/‘orted that a monoclonal antibody against TCPP (meso- 
I atrakis(4-carboxyphenyl)porphyine) was raised but enzymatic 
ctivity as a catalytic antibody was not characterized [8,9]. 
’ Creation of a catalytic antibody using N-methylmeso-porphy- 
in 1X, a presumed transition-state analogue for porphyrin 
laetalation as a hapten was also reported [lo]. This antibody- 
ijorphyrin complex was formed to catalyze the reduction of 
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hydrogen peroxide by several typical chromogenic peroxidase 
substrates [lo]. We synthesized TCPP that exhibits higher sub- 
strate specificity than N-methylmeso-porphyrin IX as a hapten 
and monoclonal antibodies were raised. Surprisingly, recombi- 
nant antibody L chains were found to have specific interaction 
with porphyrin. Furthermore, one of the L-chain-porphyrin 
complex exhibited higher thermostable peroxidase activity than 
the complex of whole antibody and porphyrin. 
2. Materials and methods 
2.1. Preparation oj’ monoclonal antibody 
TCPP was synthesized as reported previously [9]. In order to raise 
monoclonal antibody, TCPP was covalently attached to the carrier 
protein, keyhole limpet hemocyanin (KLH) using water-soluble car- 
bodiimide or I-(3-dimethylamino)propyl-3-ethyl-carbodiimide. The 
conjugates were then purified by column chromatography on Sephadex 
G-50. Balb/c mice were immunized with the KLH conjugate emulsified 
in complete Freund’s adjuvant. Cell fusion was carried out using 
P3X63-Ag8.653 myeloma as the fusion partner and polyethylene glycol 
as the fusion reagent. Two hybridoma cells (03-1, 13-1) were screened 
and propagated in ascites as described previously [9]. Two monoclonal 
antibodies from hybridoma cells (Mab03-1, Mabl3-1) were purified by 
using protein A column. Specific interaction of Mab03-I and Mabl3-1 
with TCPP was examined by ELISA (enzyme-linked immunosorbent 
assay) [I l] and purified monoclonal antibodies were used for further 
studies. 
2.2. Cloning and nucleotide sequencing of antibody genes 
Hybridoma cells, 03-l and 13-1, were cultivated and cellular mRNA 
was purified by Quick Prep mRNA Purification kit (Pharmacia P-L 
Biochemicals Inc., Milwaukee, WI). Isolated mRNA was then used to 
construct the cDNA library using oligo(dT),, primer and reverse tran- 
scriptase. Genes for both L and H chains of two monoclonal antibodies 
(Mab03-1, Mabl3-1) were amplified using PCR (polymerase chain 
reaction) and cloned into lmmunozap L and H vectors [12], respec- 
tively. Nucleotide sequences of the cloned DNA fragments encoding L 
and H chains were determined by dideoxy chain termination method 
[13]. Nucleotide sequences were confirmed by asymmetric PCR fol- 
lowed by direct sequencing [14]. 
2.3. Expression of antibody genes 
Genes for the appropriate L and H chains were subcloned respec- 
tively into an expression vector, PET&C, which has a strong promoter 
sequence for T7RNA polymerase 1151. Expression of each antibody 
gene was induced by IPTG (final concentration 0.1 mM). Three hours 
after the induction, E. coli cells were harvested by centrifugation. Cells 
were then broken by sonication and insoluble fraction was recovered 
by centrifugation. Insoluble fraction was treated with 2% Triton X-100, 
10 mM EDTA (pH 8.0) and sonicated. Inclusion bodies were harvested 
by centrifugation and washed twice with a buffer (30 mM Tris-HCI, 30 
mM NaCl, pH 8.0). The inclusion body fraction was solublized in a 
solution of 6 M guanidine hydrochloride, 40 mM Tris-HCl, 1 mM 
dithiothreitol (DTT) pH 8.0. The protein was refolded by dialysis 
against a refolding buffer (40 mM Tris-HCl, 1 mM DTT). Homogeneity 
of proteins were confirmed by SDS gel electrophoresis. Binding be- 
tween porphyrin and antibody proteins was tested by ELISA [l I]. 
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Fig. 1. Amino acid sequences of L chains (Mab03-1, Mabl3-1) and H 
chains (Mab03-1, Mabl3-1) derived from nucleotide sequence deter- 
mined by dideoxy method [13]. The nucleotide sequences were regis- 
tered by GenBank Accession No. D29667 (H chain of Mab03-1), 
D29668 (L chain of Mab03-1), D29669 (H chain of Mabl3-1) and 
D29670 (L chain of Mabl3-1). Conserved amino acid residues were 
surrounded by boxes. Three CDRs (complementarity determining re- 
gion; CDRl-CDR3) were indicated below the amino acid sequence. 
2.4. Measurement of dissociation constants 
Kinetics of binding was more precisely analyzed by determination of 
dissociation constants. Fluorescence measurements were performed on 
a Shimadzu spectrofluorophotometer RF-5020 using wavelength from 
300 nm to 450 nm and peak value was detected at wavelength 340 nm. 
Dissociation constants (KJ for Mab03-1, Mabl3-1 and two L chains 
were determined from the slope of the Scatchard plot based on the 
fluorescence quenching of peak values at 340 nm [16,17]. 
2.5. Assay of peroxidase activity 
The reaction for peroxidase activity was performed at 37°C as fol- 
lows. Reaction mixture containing 5.0 x 10e7 M TCPP Fe(III), 
8.0 x lo-’ M antibody protein, 1.2 x lo-’ M substrate, and 5.0 x 1O-3 
M hydrogen peroxide dissolved into TAB buffer (90 mM Tris-acetate 
pH 8.0) was prepared and incubated at 37°C. Absorbance of wave- 
length at 420 nm (pyrogallol) or 414 nm (ABTS) was monitored by 
Shimadzu UV160 UV-visible recording spectrophotometer. The reac- 
tion mixtures without antibody protein and with BSA (bovine serum 
albumin) at the same concentration were prepared as controls. 
Fig. 2. Reaction scheme of pyrogallol (A) and ABTS (B) by peroxidase 
and peroxidase reaction by complexes of antibody proteins and TCPP 
Fe(III). Symbols: W, a, 0, o and ??indicate TCPP Fe(II1) with none, 
BSA, Mab03-1, 03-l L chain, and 13-1 L chain, respectively. 
3. Results and discussion 
3.1. Nucleotide and amino acid sequences of monoclonal 
antibodies 
Nucleotide sequence of the genes for Mab03-1 and Mabl3- 1 
was determined (GenBank Access. No. D29667-D29670) and 
the deduced amino acid sequences were compared between the 
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1 ig. 3. Detection of purpurogallin by gas chromatography. Reaciion 
nlixture with the 13-1 L chain complexed with TCPP Fe(N) was pre- 
pared as explained above. Bottom is for control sample of pur- 
rurogallin and upper profile is for extractant from the reaction mixture. 
t *vo antibodies (Fig. 1). Amino acid sequences of these antibod- 
i :s were found to be different especially in hyper variable re- 
rions (CDR-1, -2 and -3) of H chain. 
. .2. Expression and recovery of recombinant antibody proteins 
Overexpression of antibody protein was performed using 
I:. coli BL21(DE3) as a host and antibody proteins could be 
I ecovered as inclusion bodies in insoluble cytoplasmic fraction. 
f I chains from both monoclonal antibodies did not show anti- 
; en binding, while specific binding between independent anti- 
llody L chain and TCPP was observed for both 03-l and 13-1 
ntibodies (data not shown). 
.3. Dissociation constants of antibody proteins 
Kd values were measured for antibody proteins by fluores- 
I ence quenching as explained in section 2. Specific interaction 
1 If independent 03-l L chain (Kd = 2.4 x 10s6 M) and 13-1 L 
t hain (Kd = 2.6 x 10m6 M) with TCPP was observed. However, 
& values of L chains were higher than those of Mab03-1 
I Kd = 6.4 x lo-* M) and Mabl3-1 (Kd = 1.0 x lo-’ M). Most of 
“hese antibody proteins had specific interaction even with 
XPP Fe(III), while Mabl3-1 did not. Kd values of Mab03-1, 
113-lLand13-lLwithTCPPFe(III)arelSx lo-‘M, 1.0x 10m5 
‘vi, and 1.4 x 10e5 M, respectively. 
Some naturally occurring active antibodies composed of 
leavy chain dimers and devoid of L chain have been reported 
181. Recombinant single immunoglobulin variable domains of 
II chain secreted from E. coli had specific binding activities [ 191. 
lowever, specific antigen binding by L chain is very rare case. 
r.4. Assay of peroxidase activity 
Peroxidase activity was tested for Mab03-1 and Mab13-1 L 
:hain complexes with TCPP Fe(II1) using pyrogallol as a sub- 
-trate, and compared with those of TCPP Fe(II1) alone and 
Mab03-l&TCPP Fe(II1) (Fig. 2A). The L chain of MabOS-1 
:xhibits slightly higher activity than TCPP Fe(II1) but the activ- 
ty was still lower than that of Mab03-1. Interestingly, 13-1 L 
.:hain exhibited much higher peroxidase activity than Mab03-1. 
rhis result and the observation that Mabl3-1 did not bind to 
XPP Fe(II1) suggested that H chain of Mabl3-1 antibody 
night interrupt the binding of TCPP Fe(II1). 
This resultant complex of 13-1 antibody L chain and TCPP 
Fe(II1) exhibited the highest peroxidase activity among all the 
tested and previously reported catalytic antibodies. Final reac- 
tion mixture was tested for detection of purpurogallin, an end 
product of peroxidase reaction from pyrogallol. Identical pro- 
files of photometric assay was observed (data not shown). Fur- 
ther characterization by gas chromatography confirmed that 
the L chain complexed with TCPP Fe(II1) catalyzes peroxidase 
reaction from pyrogallol as a catalytic antibody (Fig. 3). 
Michaelis constants (Km) and catalytic constants (kcat) were 
determined by Lineweaver-Burk plot. K,,, values were 2.3 mM 
(H202) and 4.0 mM (pyrogallol) and k,,, value was 667 min-’ 
for both H,O, and pyrogallol. Tentatively, we named this anti- 
body L chain with peroxidase activity ‘L-zyme’. 
3.5. Specljicitv of the peroxidase activity 
Specificity of the peroxidase activity was also examined using 
different substrates (ABTS (2,2-azinobis-3-ethylbenz-thiazolin- 
6-sulfonic acid) and catechol). Significant peroxidase activity 
for ABTS was observed using the complex of 13-1 L chain and 
TCPP Fe(II1) (Fig. 2B). Yet, no activity was detected when 
catechol was used as a substrate (data not shown). 
3.6. Thermostability of the peroxidase activity 
Peroxidase activity of L-zyme was examined at different tem- 
peratures and compared with the case of TCPP Fe(II1) (Fig. 4). 
The optimum temperature of the reaction by L-zyme is ex- 
tremely high (9O’C) (Fig. 4) while that by TCPP Fe(II1) is only 
60°C. Its specific activity at elevated temperature (>SO’C) is 
even higher than that of horse radish peroxidase (data not 
shown). 
We have demonstrated that independent L chains from mon- 
oclonal antibodies can recognize and interact with TCPP and 
TCPP Fe(II1). The complex of L chain and TCPP Fe(II1) (L- 
zyme) exhibited much higher peroxidase activity and extreme 
thermostability than TCPP Fe(II1) alone or Mab03-1 with 
TCPP Fe(II1). 
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Fig. 4. Peroxidase activity at different temperatures. The activity was 
tested at different temperatures from 20°C to 100°C as explained in 
legend of Fig. 2. Initial velocity of catalysis is monitored for 5 s and 
dA,& was calculated. Symbols: ??and u are for the complex of 13-1 
L chain and TCPP Fe(III), and TCPP Fe(II1) alone, respectively. 
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We are now determining the molecular structure of this new 
catalytic antibody by X-ray crystallography and NMR to eluci- 
date structure-function relationship of this new catalytic anti- 
body. 
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